What crystal deposition causes pseudogout?
Calcium pyrophosphate dihydrate (CPPD) crystal deposition in the synovium.
What is the more accurate modern name for pseudogout?
Acute calcium pyrophosphate crystal deposition disease.
What type of arthritis process is pseudogout classified as?
A microcrystal synovitis.
What is the strongest risk factor for developing pseudogout?
Increasing age.
What should be suspected if pseudogout occurs in patients <60 years old?
An underlying metabolic or systemic risk factor.
Which metabolic conditions predispose to pseudogout?
Haemochromatosis, hyperparathyroidism, low magnesium, low phosphate.
Which endocrine/metabolic diseases increase pseudogout risk?
Acromegaly and Wilson’s disease.
Which joints are most commonly affected in pseudogout?
Knee, wrist, and shoulder joints.
How does acute pseudogout typically present clinically?
Acute monoarthritis with pain, swelling, erythema, and warmth.
What is the characteristic synovial fluid finding in pseudogout?
Weakly positively birefringent, rhomboid-shaped CPPD crystals.
What is the key X-ray feature of pseudogout?
Chondrocalcinosis.
How does chondrocalcinosis of the knee appear on an X-ray?
Linear calcifications of the meniscus and articular cartilage.
Why is joint aspiration essential in pseudogout assessment?
To exclude septic arthritis.
What procedure is performed first when pseudogout is suspected?
Aspiration of joint fluid to rule out septic arthritis.
Which medications are used to treat acute pseudogout?
NSAIDs or steroids (intra-articular, intramuscular, or oral).
Which steroid route can be used for pseudogout management besides oral therapy?
Intra-articular or intramuscular steroid injections.